For­mer Za­cks biotech an­a­lyst Napo­dano charged with fraud af­ter set­tling with SEC on in­sid­er trad­ing cas­es

Ja­son Napo­dano gained some wide­spread recog­ni­tion in a cer­tain group of biotech in­vestors and Twit­ter mavens while he was the se­nior biotech an­a­lyst at Za­cks Small Cap Re­search. But for around three years, while Napo­dano was pro­vid­ing cov­er­age on a slate of mi­cro cap biotechs, he and a pair of col­leagues in the bro­ker­age busi­ness al­so ran a pen­ny ante in­sid­er trad­ing ring, al­leged­ly shar­ing in­for­ma­tion as they schemed up ways to make thou­sands of dol­lars off the pen­ny stocks he cov­ered.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.